Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Real Estate Companies: Healthpeak Properties (DOC) and FirstService (FSV)

Tipranks - Tipranks - Wed Apr 15, 8:52AM CDT

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Healthpeak Properties (DOC) and FirstService (FSV) with bullish sentiments.

Claim 30% Off TipRanks

Healthpeak Properties (DOC)

In a report released today, Farrell Granath from Bank of America Securities maintained a Buy rating on Healthpeak Properties, with a price target of $20.00. The company’s shares closed last Tuesday at $16.86.

According to TipRanks.com, Granath is a 3-star analyst with an average return of 5.6% and a 62.5% success rate. Granath covers the NA sector, focusing on stocks such as Sabra Healthcare REIT, Alexandria Equities, and Omega Healthcare. ;'>

Currently, the analyst consensus on Healthpeak Properties is a Moderate Buy with an average price target of $18.94, which is a 14.8% upside from current levels. In a report issued on April 6, Robert W. Baird also maintained a Buy rating on the stock with a $19.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

FirstService (FSV)

Stifel Nicolaus analyst Daryl Young maintained a Buy rating on FirstService today and set a price target of $215.00. The company’s shares closed last Tuesday at $149.62, close to its 52-week low of $141.26.

According to TipRanks.com, Young is a 4-star analyst with an average return of 6.1% and a 52.5% success rate. Young covers the Industrial Goods sector, focusing on stocks such as Air Canada, Cargojet, and CAE. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for FirstService with a $207.00 average price target, a 39.2% upside from current levels. In a report issued on March 30, TipRanks – PerPlexity also upgraded the stock to Buy with a C$209.00 price target.

Read More on DOC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).